The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Typhoid Vaccine Market Research Report 2025
Synopsis
The global Typhoid Vaccine market was valued at US$ 11900 million in 2023 and is anticipated to reach US$ 16050 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Typhoid Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Typhoid Vaccine.
Report Scope
The Typhoid Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Typhoid Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Typhoid Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Merck
GlaxoSmithKline
PaxVax
Actiza Pharmaceutical
Merit Pharmaceuticals
Bharat Biotec
Segment by Type
Oral Type Typhoid Vaccine
Injection Type Typhoid Vaccine
Segment by Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Typhoid Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Typhoid Vaccine market was valued at US$ 11900 million in 2023 and is anticipated to reach US$ 16050 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Typhoid Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Typhoid Vaccine.
Report Scope
The Typhoid Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Typhoid Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Typhoid Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Merck
GlaxoSmithKline
PaxVax
Actiza Pharmaceutical
Merit Pharmaceuticals
Bharat Biotec
Segment by Type
Oral Type Typhoid Vaccine
Injection Type Typhoid Vaccine
Segment by Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Typhoid Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Typhoid Vaccine Market Overview
1.1 Product Overview and Scope of Typhoid Vaccine
1.2 Typhoid Vaccine Segment by Type
1.2.1 Global Typhoid Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Oral Type Typhoid Vaccine
1.2.3 Injection Type Typhoid Vaccine
1.3 Typhoid Vaccine Segment by Application
1.3.1 Global Typhoid Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Global Typhoid Vaccine Market Size Estimates and Forecasts
1.4.1 Global Typhoid Vaccine Revenue 2019-2030
1.4.2 Global Typhoid Vaccine Sales 2019-2030
1.4.3 Global Typhoid Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Typhoid Vaccine Market Competition by Manufacturers
2.1 Global Typhoid Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Typhoid Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Typhoid Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Typhoid Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Typhoid Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Typhoid Vaccine, Product Type & Application
2.7 Typhoid Vaccine Market Competitive Situation and Trends
2.7.1 Typhoid Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Typhoid Vaccine Players Market Share by Revenue
2.7.3 Global Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Typhoid Vaccine Retrospective Market Scenario by Region
3.1 Global Typhoid Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Typhoid Vaccine Global Typhoid Vaccine Sales by Region: 2019-2030
3.2.1 Global Typhoid Vaccine Sales by Region: 2019-2024
3.2.2 Global Typhoid Vaccine Sales by Region: 2025-2030
3.3 Global Typhoid Vaccine Global Typhoid Vaccine Revenue by Region: 2019-2030
3.3.1 Global Typhoid Vaccine Revenue by Region: 2019-2024
3.3.2 Global Typhoid Vaccine Revenue by Region: 2025-2030
3.4 North America Typhoid Vaccine Market Facts & Figures by Country
3.4.1 North America Typhoid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Typhoid Vaccine Sales by Country (2019-2030)
3.4.3 North America Typhoid Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Typhoid Vaccine Market Facts & Figures by Country
3.5.1 Europe Typhoid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Typhoid Vaccine Sales by Country (2019-2030)
3.5.3 Europe Typhoid Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Typhoid Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Typhoid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Typhoid Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Typhoid Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Typhoid Vaccine Market Facts & Figures by Country
3.7.1 Latin America Typhoid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Typhoid Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Typhoid Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Typhoid Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Typhoid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Typhoid Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Typhoid Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Typhoid Vaccine Sales by Type (2019-2030)
4.1.1 Global Typhoid Vaccine Sales by Type (2019-2024)
4.1.2 Global Typhoid Vaccine Sales by Type (2025-2030)
4.1.3 Global Typhoid Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Typhoid Vaccine Revenue by Type (2019-2030)
4.2.1 Global Typhoid Vaccine Revenue by Type (2019-2024)
4.2.2 Global Typhoid Vaccine Revenue by Type (2025-2030)
4.2.3 Global Typhoid Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Typhoid Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Typhoid Vaccine Sales by Application (2019-2030)
5.1.1 Global Typhoid Vaccine Sales by Application (2019-2024)
5.1.2 Global Typhoid Vaccine Sales by Application (2025-2030)
5.1.3 Global Typhoid Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Typhoid Vaccine Revenue by Application (2019-2030)
5.2.1 Global Typhoid Vaccine Revenue by Application (2019-2024)
5.2.2 Global Typhoid Vaccine Revenue by Application (2025-2030)
5.2.3 Global Typhoid Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Typhoid Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Typhoid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Typhoid Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Typhoid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Typhoid Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Typhoid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Typhoid Vaccine Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 PaxVax
6.4.1 PaxVax Corporation Information
6.4.2 PaxVax Description and Business Overview
6.4.3 PaxVax Typhoid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PaxVax Typhoid Vaccine Product Portfolio
6.4.5 PaxVax Recent Developments/Updates
6.5 Actiza Pharmaceutical
6.5.1 Actiza Pharmaceutical Corporation Information
6.5.2 Actiza Pharmaceutical Description and Business Overview
6.5.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Actiza Pharmaceutical Typhoid Vaccine Product Portfolio
6.5.5 Actiza Pharmaceutical Recent Developments/Updates
6.6 Merit Pharmaceuticals
6.6.1 Merit Pharmaceuticals Corporation Information
6.6.2 Merit Pharmaceuticals Description and Business Overview
6.6.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merit Pharmaceuticals Typhoid Vaccine Product Portfolio
6.6.5 Merit Pharmaceuticals Recent Developments/Updates
6.7 Bharat Biotec
6.6.1 Bharat Biotec Corporation Information
6.6.2 Bharat Biotec Description and Business Overview
6.6.3 Bharat Biotec Typhoid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bharat Biotec Typhoid Vaccine Product Portfolio
6.7.5 Bharat Biotec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Typhoid Vaccine Industry Chain Analysis
7.2 Typhoid Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Typhoid Vaccine Production Mode & Process
7.4 Typhoid Vaccine Sales and Marketing
7.4.1 Typhoid Vaccine Sales Channels
7.4.2 Typhoid Vaccine Distributors
7.5 Typhoid Vaccine Customers
8 Typhoid Vaccine Market Dynamics
8.1 Typhoid Vaccine Industry Trends
8.2 Typhoid Vaccine Market Drivers
8.3 Typhoid Vaccine Market Challenges
8.4 Typhoid Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
